scarfc soluble receptor analogue experimental prophylactic treatment coxsackievirus cvb infections coxsackievirus cause cardiac damage eventually resulting weakened enlarged heart termed dilated many treatments inhibit viral proliferation myocytes scarfc prevents virus entering cell competitively binding coxsackie virus adenovirus receptors car membrane myocytes coxsackievirus singlestranded rna enterovirus member picornavirdae virus penetrates hosts systemic circulation via contaminated water food travel infect heart cause myocarditis myocarditis inflammation heart commonly cause viral infections amongst viruses capable causing myocarditis common agent identified inducing cardiac damage internalization virus myocytes occurs binding coxsackievirusadenovirus receptors car located tight junctions cell inside cytoplasm virus use hosts ribosomal machinery proliferate replicate progenies extensive cardiac necrosis occur day three infection incubated viruses lyse myocytes resulting severe rapid cardiac decompensation loss cardiac cells increasing progressively infected individual experience abnormalities left ventricular systolic diastolic function well electrical conduction defects manifesting cardiac result ejection fraction decreases cytolytic destruction heart cells lead dilated cardiomyopathy treated appropriatelycitation needed role immune system response presence virus beneficial detrimental effects cardiac arrival natural killer cells nk cells site infection limits viral proliferation myocytes conversely certain cytokines released immune cells protective effects others tumor necrosis factoralpha tnfÎ± deleterious effects heart cells moreover peak concentrations cells myocardium days play important roles viral clearance immune mediated cardiac damage tcells lyse destroy infected myocytes due molecular mimicry also destroy normal healthy cardiac cells driving heart towards dilated synthetic soluble form car scar created prevent viral infection attaching fc domain immunoglobulin scar scarfc enhances solubility extends furthermore scarfc binds virus macrophages phagocytic immune cells fc receptor recognition bind scarfcviral complex eliminate virus essentially scarfc mimics car receptors cardiac cells competitively inhibiting viral attachment entry myocytes decreased lesions cardiac tissues reduced cell necrosis diminished inflammatory responses observed scarfc treated cells cite suggests protective effects myocardial damage needed conformational changes viral particle aparticle scarfcvirus binding causing loss virus internal capsid protein irreversible reaction prevents virus interacting cellular receptors car cardiac cells decreasing infectivity administration scarfc beyond three days initial exposure virus beneficial effects cardiac damage use scarfc currently limited prophylactic treatmentscitation needed httpsenwikipediaorgwikiscarfc